About Cytochrome c1, heme protein, mitochondrial
Cytochrome c1, heme protein, mitochondrial (CYC1) is a protein
from Homo sapiens identified by UniProt accession
P08574, 325 residues long.
MolForge cross-references it against 0 known binders and
57 disease associations.
Target properties
| Protein name | Cytochrome c1, heme protein, mitochondrial |
| UniProt accession | P08574 |
| Gene | CYC1 |
| Organism | Homo sapiens |
| Length | 325 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (57)
Diseases linked to this target (Open Targets).
- Isolated CoQ-cytochrome C reductase deficiency · score 0.77
- neurodegenerative disease · score 0.54
- neuroinflammatory disorder · score 0.19
- mitochondrial disease · score 0.19
- mean corpuscular hemoglobin concentration · score 0.18
- mean corpuscular volume · score 0.12
- mean corpuscular hemoglobin · score 0.11
- blood metabolite measurement · score 0.09
- eosinophil count · score 0.09
- mean reticulocyte volume · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P08574-F1 | alphafold | PREDICTED | 84.92 | — |
Amino-acid sequence (325 residues)
MAAAAASLRG VVLGPRGAGL PGARARGLLC SARPGQLPLR TPQAVALSSK SGLSRGRKVM LSALGMLAAG GAGLAMALHS AVSASDLELH PPSYPWSHRG LLSSLDHTSI RRGFQVYKQV CASCHSMDFV AYRHLVGVCY TEDEAKELAA EVEVQDGPNE DGEMFMRPGK LFDYFPKPYP NSEAARAANN GALPPDLSYI VRARHGGEDY VFSLLTGYCE PPTGVSLREG LYFNPYFPGQ AIAMAPPIYT DVLEFDDGTP ATMSQIAKDV CTFLRWASEP EHDHRKRMGL KMLMMMALLV PLVYTIKRHK WSVLKSRKLA YRPPK
Explore Cytochrome c1, heme protein, mitochondrial with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets